ESC Premium Access

Feasibility and efficacy of early donepezil with or without metoprolol in reperfused myocardial infarction rats

Congress Presentation

About the speaker

Doctor Meihua Li

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)
0 follower

6 more presentations in this session

The best of two worlds: Vascular protection and decongestion without RAAS stimulation mediated by a novel dual acting V1a/V2 vasopressin receptor antagonist

Speaker: Doctor P. Kolkhof (Wuppertal, DE)


Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure

Speaker: Mr Y. Chen (Rochester, US)


Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat

Speaker: Doctor H. Yip (Kaohsiung, TW)


Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

Speaker: Miss J. Moellmann (Aachen, DE)


Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition

Speaker: Professor S. Verma (Toronto, CA)


Access the full session

Targeting reverse remodelling in heart failure

Speakers: Doctor M. Li, Doctor P. Kolkhof, Mr Y. Chen, Doctor H. Yip, Miss J. Moellmann...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb